BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18490707)

  • 1. Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells.
    Briso EM; Dienz O; Rincon M
    J Immunol; 2008 Jun; 180(11):7102-6. PubMed ID: 18490707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.
    Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B
    J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
    Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
    Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
    J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling.
    Flynn CM; Garbers Y; Lokau J; Wesch D; Schulte DM; Laudes M; Lieb W; Aparicio-Siegmund S; Garbers C
    Sci Rep; 2019 May; 9(1):7306. PubMed ID: 31086276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
    Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
    Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.
    Garbers C; Jänner N; Chalaris A; Moss ML; Floss DM; Meyer D; Koch-Nolte F; Rose-John S; Scheller J
    J Biol Chem; 2011 Apr; 286(17):14804-11. PubMed ID: 21454673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE).
    Matthews V; Schuster B; Schütze S; Bussmeyer I; Ludwig A; Hundhausen C; Sadowski T; Saftig P; Hartmann D; Kallen KJ; Rose-John S
    J Biol Chem; 2003 Oct; 278(40):38829-39. PubMed ID: 12832423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling.
    Arnold P; Boll I; Rothaug M; Schumacher N; Schmidt F; Wichert R; Schneppenheim J; Lokau J; Pickhinke U; Koudelka T; Tholey A; Rabe B; Scheller J; Lucius R; Garbers C; Rose-John S; Becker-Pauly C
    Sci Rep; 2017 Mar; 7():44053. PubMed ID: 28276471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).
    Garbers C; Kuck F; Aparicio-Siegmund S; Konzak K; Kessenbrock M; Sommerfeld A; Häussinger D; Lang PA; Brenner D; Mak TW; Rose-John S; Essmann F; Schulze-Osthoff K; Piekorz RP; Scheller J
    Cell Cycle; 2013 Nov; 12(21):3421-32. PubMed ID: 24047696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2.
    Velásquez SY; García LF; Opelz G; Alvarez CM; Süsal C
    Transplantation; 2013 Jul; 96(2):154-61. PubMed ID: 23857000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.
    Schumacher N; Schmidt S; Schwarz J; Dohr D; Lokau J; Scheller J; Garbers C; Chalaris A; Rose-John S; Rabe B
    J Immunol; 2016 Nov; 197(9):3705-3715. PubMed ID: 27698010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
    Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
    J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation.
    Riethmueller S; Somasundaram P; Ehlers JC; Hung CW; Flynn CM; Lokau J; Agthe M; Düsterhöft S; Zhu Y; Grötzinger J; Lorenzen I; Koudelka T; Yamamoto K; Pickhinke U; Wichert R; Becker-Pauly C; Rädisch M; Albrecht A; Hessefort M; Stahnke D; Unverzagt C; Rose-John S; Tholey A; Garbers C
    PLoS Biol; 2017 Jan; 15(1):e2000080. PubMed ID: 28060820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
    Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
    J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
    Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
    Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
    Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
    Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface.
    Sugaya S; Sakimoto T; Shoji J; Sawa M
    Jpn J Ophthalmol; 2011 May; 55(3):277-282. PubMed ID: 21523377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).
    Möller-Hackbarth K; Dewitz C; Schweigert O; Trad A; Garbers C; Rose-John S; Scheller J
    J Biol Chem; 2013 Nov; 288(48):34529-44. PubMed ID: 24121505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.